Genetics Generation Advancement Corp. (TPEX:4160)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.55
+0.35 (0.87%)
Jul 21, 2026, 1:22 PM CST
Market Cap1.07B -17.4%
Revenue (ttm)609.13M -4.6%
Net Income13.89M -71.1%
EPS0.52 -71.1%
Shares Out 26.69M
PE Ratio77.32
Forward PEn/a
Dividend1.85 (4.63%)
Ex-Dividend DateOct 3, 2025
Volume26,157
Open40.20
Previous Close40.20
Day's Range40.00 - 41.00
52-Week Range39.05 - 60.50
Beta0.34
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About TPEX:4160

Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services. It also provides AI and data applications, such as bioinformatic, materials sciences, research and d... [Read more]

Sector Healthcare
Founded 2008
Employees 104
Stock Exchange Taipei Exchange
Ticker Symbol 4160
Full Company Profile

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.

Financial Statements